U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06922708) titled 'Implementing Polygenic Risk Scores for Breast Cancer Prevention: a Feasibility Study' on March 27.
Brief Summary: The goal of this single-arm interventional study is to learn whether integrating a polygenic risk score (PRS) into the CanRisk model can help improve breast cancer risk prediction and prevention in adult women with or without a family history of breast cancer and in women diagnosed with unilateral breast cancer. The main questions it aims to answer are:
1. Is it feasible and acceptable to add PRS testing into standard breast cancer risk assessment for healthcare professionals and patients?
2. Does PRS testing change t...